ArticleHepatology communications2026

Reconsidering antiviral prophylaxis in HBsAg-negative, anti-HBc-positive patients treated with rituximab.

George Papatheodoridis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.